Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo

US9636423B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9636423-B2
Application numberUS-201113700255-A
CountryUS
Kind codeB2
Filing dateJun 2, 2011
Priority dateJun 2, 2010
Publication dateMay 2, 2017
Grant dateMay 2, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides methods and compositions based on optical sensor conjugates that are useful for detecting reactive oxygen, reactive nitrogen, or both species that are a direct result of inflammation caused by tissue damage.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of imaging reactive oxygen species, reactive nitrogen species, or both in a subject, the method comprising: administering to the subject an optical sensor conjugate comprising a fluorogenic small molecule, a particle or polymer, and a linker that connects the small molecule to the particle or polymer, for a time sufficient for the small molecule to react with the reactive oxygen or reactive nitrogen, or both, thereby releasing the small molecule from the optical sensor conjugate and becoming fluorescent; and obtaining a fluorescence image of the small molecule in the subject, thereby imaging the subject, wherein the small molecule with the linker comprises a compound of Formula I: wherein: Z is the linker and comprises C 3-20 alkyl, wherein any of the carbons in C 3-20 alkyl can be replaced with —C(O)—, C(O)O—, —C(O)NR A —, —C(NH)—, oxygen, sulfur, —SO 2 —, —NR A SO 2 — —NR A —; X is selected from  N 3 , C(O)Cl, and C(O)OR A ; Y is selected from O, S, Se, Te, N(R A ), and C(Me) 2 ; R 1 is selected from H, C 1-6 alkyl, OR A , and NR C R D , wherein said C 1-6 alkyl is optionally substituted by OR A or NR C R D ; or 2 or 3 R 1 adjacent to each other and together with the C atoms to which they are attached form 1or 2 heterocycloalkyl, optionally substituted by 1, 2, 3, or 4 substituents independently selected from H, OH, C 1-6 alkyl, OR A , C(O)R B , C(O)NR C R D , and C(O)OR A ; R A , R B , R C and R D are independently selected from H, C 1-6 alkyl, and succinimidyl; and m is 1, 2, 3, or 4. 2. The method of claim 1 , wherein X is C(O)OR A and Y is O. 3. The method of claim 1 , wherein R 1 is NR C R D . 4. The method of claim 1 , wherein the compound is 5. The method of claim 1 , wherein the particle or polymer further comprises a reporting agent. 6. The method of claim 1 , wherein the fluorescence image is obtained by fluorescence microscopy. 7. The method of claim 1 , wherein the optical sensor conjugate is used in an in vitro assay. 8. The method of claim 1 , wherein the subject is a mammal. 9. The method of claim 1 , wherein the reactive oxygen, reactive nitrogen, or both are associated with inflammation. 10. The method of claim 9 , wherein the inflammation is associated with tissue injury. 11. The method of claim 9 , wherein the reactive oxygen, reactive nitrogen, or both are associated with Alzheimer's disease, atherosclerosis, cancer, stroke, inflammatory bowel disease, or organ transplantation.

Assignees

Inventors

Classifications

  • Antineoplastic agents · CPC title

  • Macromolecular compounds, i.e. oligomers, polymers, dendrimers · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle · CPC title

  • A61K49/003Primary

    Thiazine dyes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9636423B2 cover?
The present invention provides methods and compositions based on optical sensor conjugates that are useful for detecting reactive oxygen, reactive nitrogen, or both species that are a direct result of inflammation caused by tissue damage.
Who is the assignee on this patent?
Hilderbrand Scott A, Weissleder Ralph, Panizzi Peter, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61K49/003. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).